Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.8150 (-8.5%) ($10.8150 - $10.8150) on Tue. Mar. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.97% (three month average) | RSI | 48 | Latest Price | $10.8150(-8.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -3.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(37%) ARKK(35%) IWC(35%) | Factors Impacting BCRX price | BCRX will decline at least -3.485% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-7%) IGOV(-7%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.485% (StdDev 6.97%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $12.11 | 5 Day Moving Average | $12.38(-12.64%) | 10 Day Moving Average | $12.73(-15.04%) | 20 Day Moving Average | $12.11(-10.69%) | To recent high | -20.7% | To recent low | 53.5% | Market Cap | $1.908b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |